ES2144392T3 - Vectores de expresion para la sintesis de proteinas en la levadura de escision schizosaccharomyces pombe. - Google Patents

Vectores de expresion para la sintesis de proteinas en la levadura de escision schizosaccharomyces pombe.

Info

Publication number
ES2144392T3
ES2144392T3 ES90103790T ES90103790T ES2144392T3 ES 2144392 T3 ES2144392 T3 ES 2144392T3 ES 90103790 T ES90103790 T ES 90103790T ES 90103790 T ES90103790 T ES 90103790T ES 2144392 T3 ES2144392 T3 ES 2144392T3
Authority
ES
Spain
Prior art keywords
proteins
synthesis
vectors
excision
yeast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90103790T
Other languages
English (en)
Inventor
Michael Dr Broker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2144392T3 publication Critical patent/ES2144392T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1025Acyltransferases (2.3)
    • C12N9/104Aminoacyltransferases (2.3.2)
    • C12N9/1044Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

EL INVENTO DESCRIBE UN VECTOR DE EXPRESION PARA LA SINTESIS DE PROTEINAS EN LA DISGREGACION DE LEVADURA POR SCHIZOSACCHAROMYCES PONBE (5 POMBE) Y TRATA DEL EQUIPAMIENTO DE VECTORES DE EXPRESION CON TROS ELEMENTOS QUE TIENEN PROMOTORES Y TERMINADORES HOMOLOGOS.
ES90103790T 1989-03-02 1990-02-27 Vectores de expresion para la sintesis de proteinas en la levadura de escision schizosaccharomyces pombe. Expired - Lifetime ES2144392T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3906540A DE3906540A1 (de) 1989-03-02 1989-03-02 Expressionsvektoren zur synthese von proteinen in der spalthefe schizosaccharomyces pombe

Publications (1)

Publication Number Publication Date
ES2144392T3 true ES2144392T3 (es) 2000-06-16

Family

ID=6375272

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90103790T Expired - Lifetime ES2144392T3 (es) 1989-03-02 1990-02-27 Vectores de expresion para la sintesis de proteinas en la levadura de escision schizosaccharomyces pombe.

Country Status (11)

Country Link
US (1) US5663061A (es)
EP (1) EP0385391B1 (es)
JP (1) JP3100145B2 (es)
KR (1) KR0166582B1 (es)
AT (1) ATE189479T1 (es)
AU (1) AU623749B2 (es)
CA (1) CA2011304C (es)
DE (2) DE3906540A1 (es)
DK (1) DK0385391T3 (es)
ES (1) ES2144392T3 (es)
PT (1) PT93300B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4113949A1 (de) * 1991-04-29 1992-11-05 Behringwerke Ag Schizosaccharomyces spezifische polypeptide
US6379903B1 (en) * 1999-10-08 2002-04-30 Sigma-Aldrich Co. Purification of recombinant proteins fused to multiple epitopes
EP2322229B1 (en) 2001-10-10 2016-12-21 Novo Nordisk A/S Remodeling and glycoconjugation of Factor IX
WO2004099231A2 (en) 2003-04-09 2004-11-18 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
EP2292271A3 (en) 2001-10-10 2011-09-14 BioGeneriX AG Remodelling and glycoconjugation of an antibody
EP1913143A1 (en) * 2005-07-29 2008-04-23 Pharmexa A/S Improved protein expression
WO2013186788A2 (en) * 2012-06-11 2013-12-19 Council Of Scientific And Industrial Research An expression vector containing strong promoter useful for high level expression of heterologous genes in schizosaccharomyces pombe and method for production of desired proteins thereof
JP6530846B1 (ja) * 2018-10-09 2019-06-12 アサヒグループホールディングス株式会社 免疫賦活剤及び感染予防方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1164389B (it) * 1983-08-05 1987-04-08 Zambon Spa Derivati n-sostituiti dell'1-(4'-alchiltiofenil)-2-ammino-1,3-propandiolo
AU3145184A (en) * 1983-08-16 1985-02-21 Zymogenetics Inc. High expression of foreign genes in schizosaccharomyces pombe
US4931373A (en) * 1984-05-25 1990-06-05 Zymogenetics, Inc. Stable DNA constructs for expression of α-1 antitrypsin
EP0268772B1 (en) * 1986-09-19 1995-04-26 ZymoGenetics, Inc. Expression of biologically active factor XIII
DK175243B1 (da) * 1987-03-23 2004-07-19 Zymogenetics Inc Ekspressionsvektor, der er i stand til at styre ekspression af heterologe gener eller cDNA i gær, gærværtscelle samt fremgangsmåde til öget produktion af proteiner i gærværtsceller
US4929553A (en) * 1987-05-29 1990-05-29 Canadian Patents & Development Ltd. Protease for specific processing of secreted proteins

Also Published As

Publication number Publication date
AU5059290A (en) 1990-09-06
AU623749B2 (en) 1992-05-21
US5663061A (en) 1997-09-02
PT93300B (pt) 1997-12-31
EP0385391A3 (de) 1991-07-03
CA2011304A1 (en) 1990-09-02
KR900014599A (ko) 1990-10-24
DE3906540A1 (de) 1990-09-13
PT93300A (pt) 1990-11-07
EP0385391B1 (de) 2000-02-02
CA2011304C (en) 2002-10-01
DK0385391T3 (da) 2000-05-29
EP0385391A2 (de) 1990-09-05
KR0166582B1 (ko) 1999-01-15
JPH02283288A (ja) 1990-11-20
JP3100145B2 (ja) 2000-10-16
ATE189479T1 (de) 2000-02-15
DE59010897D1 (de) 2000-03-09

Similar Documents

Publication Publication Date Title
AU6690590A (en) An agent for the storage and suspension of cells, especially erythrocytes
AU7575487A (en) Method for the preparation of proteins with factor VIII activity by microbial host cells; expression, vectors, host cells, antibodies
DE3750106T2 (de) Rekombinanter B-Zell-Differenzierungsfaktor.
ATE256732T1 (de) Hautäquivalent, das langerhans-zellen enthält
DE3787805D1 (de) Serumfreies gewebekulturmedium, das ein polymerzellenschutzmittel enthält.
AU3630189A (en) Novel polypeptides with an anticoagulant activity
NO854448L (no) Sv40 ekspresjonsvektor inneholdende hbxag som en ekspresjonsmarkoer.
EP0363897A3 (en) Nematocidal preparations
EP0242552A3 (en) Flexible bearing beam, especially for bogies
ES2144392T3 (es) Vectores de expresion para la sintesis de proteinas en la levadura de escision schizosaccharomyces pombe.
AU4157685A (en) Immunosuppressant factor
ES2086383T3 (es) Deteccion de cepas fungicas mutantes.
FI884036A (fi) Rekombinerade eukariotceller, vilka producerar interleukin-2, foerfarande och och vektorer foer deras framstaellning och foerfarande foer framstaellning av interleukin-2.
CA2014948A1 (en) Genes coding for a protein having human macif activity, expression vectors containing said genes, transformant cells and proteins having human macif activity
ES2089122T3 (es) Vectores de expresion de adn recombinante y compuestos de adn que codifican la actividad de la isopenicilina n epimerasa.
NZ221712A (en) Sailboat with sliding pivotable seat on transverse beam
AU5160690A (en) Detection of pyrogens by recombinant mammalian cells
CA2060310A1 (en) Digital speech coder with vector excitation source having improved speech quality
IT8519190A0 (it) Procedimento per la lavorazione di residui contenenti nichel e vanadio.
ES2047946T3 (es) Metodos de cultivos celulares para producir proteina c activada.
DE3878988T2 (de) 1,2-Di(4-isobutylphenyl)äthylen, dessen Herstellung und Verwendung als Zwischenprodukt.
GR3003950T3 (es)
CA2003794A1 (en) Expression of hiv proteins in drosophila cells
AU4408889A (en) H. saimiri-htlv-x region vector
DE58903750D1 (de) Elektrochemischer messfuehler.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 385391

Country of ref document: ES